Clinical Trial Update: A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the pharmacodynamic properties of VIAJECT, Regular Human Insulin, and Insulin Lispro in diabetes mellitus has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Regular human insulin (human insulin (regular))
• VIAject (insulin VIAject)
• insulin lispro (insulin lispro)

Snippet

Sponsor: Biodel | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED